NASDAQ: REPLReplimune Group Inc Stock Ownership - Who owns Replimune Group?
Insider buying vs selling
Have Replimune Group Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Philip Astleysparke | Director | 2025-05-20 | 32,279 | $8.06 | $260.17kSell |
| Sushil Patel | Chief Executive Officer | 2025-05-20 | 25,105 | $8.06 | $202.35kSell |
| Christopher Sarchi | Chief Commercial Officer | 2025-05-20 | 3,749 | $8.05 | $30.18kSell |
| Andrew Schwendenman | Chief Accounting Officer | 2025-05-20 | 3,287 | $8.05 | $26.46kSell |
| Konstantinos Xynos | Chief Medical Officer | 2025-05-20 | 7,952 | $8.06 | $64.09kSell |
| Emily Luisa Hill | Chief Financial Officer | 2025-05-20 | 2,535 | $8.05 | $20.41kSell |
| Sushil Patel | Chief Executive Officer | 2024-12-16 | 10,000 | $12.42 | $124.20kSell |
| Christopher Sarchi | Chief Commercial Officer | 2024-11-18 | 5,207 | $10.78 | $56.13kSell |
| Konstantinos Xynos | Chief Medical Officer | 2024-11-18 | 7,246 | $10.78 | $78.11kSell |
| Emily Luisa Hill | Chief Financial Officer | 2024-08-16 | 8,938 | $10.18 | $90.99kSell |
REPL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when REPL insiders and whales buy or sell their stock.
REPL Shareholders
What type of owners hold Replimune Group Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Bros Advisors LP | 14.33% | 11,045,336 | $109.18M | Institution |
| Price T Rowe Associates Inc | 14.08% | 10,853,832 | $107.29M | Institution |
| Baker Bros Advisors LP | 13.12% | 10,116,095 | $100.00M | Insider |
| Omega Fund IV LP | 12.24% | 9,436,760 | $93.28M | Insider |
| Blackrock Inc | 7.86% | 6,061,895 | $59.92M | Institution |
| Redmile Group LLC | 6.35% | 4,898,527 | $48.42M | Institution |
| Hugo Alexander Slootweg | 6.12% | 4,721,449 | $46.67M | Insider |
| Forbion Capital Fund III Cooperatief Ua | 6.12% | 4,721,449 | $46.67M | Insider |
| Fcpm III Services Bv | 5.07% | 3,909,696 | $38.65M | Institution |
| Vanguard Group Inc | 4.97% | 3,833,033 | $37.89M | Institution |
REPL vs Biotech Stocks
Replimune Group Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.